170 related articles for article (PubMed ID: 12203788)
21. Loss of heterozygosity at 6p21 underlying [corrected] HLA class I downregulation in Chinese primary esophageal squamous cell carcinomas.
Yang Y; Zhang J; Miao F; Wei J; Shen C; Shen Y; Xie W
Tissue Antigens; 2008 Aug; 72(2):105-14. PubMed ID: 18721270
[TBL] [Abstract][Full Text] [Related]
22. Haploidentical hematopoietic stem cell transplantation for lymphoma with monosomy of chromosome 6 (loss of heterozygosity in the HLA region)--who should be a donor?
Ikegame K; Kaida K; Lakoma L; Ishii S; Inoue T; Kato R; Soma T; Okada M; Ogawa H
Transpl Immunol; 2012 Dec; 27(4):162-5. PubMed ID: 23000337
[TBL] [Abstract][Full Text] [Related]
23. Loss of heterozygosity, a frequent but a non-exclusive mechanism responsible for HLA dysregulation in non-Hodgkin's lymphomas.
Drénou B; Tilanus M; Semana G; Alizadeh M; Birebent B; Grosset JM; Dias P; van Wichen D; Arts Y; De Santis D; Fauchet R; Amiot L
Br J Haematol; 2004 Oct; 127(1):40-9. PubMed ID: 15384976
[TBL] [Abstract][Full Text] [Related]
24. Mutations in the HLA class II genes leading to loss of expression of HLA-DR and HLA-DQ in diffuse large B-cell lymphoma.
Jordanova ES; Philippo K; Giphart MJ; Schuuring E; Kluin PM
Immunogenetics; 2003 Jul; 55(4):203-9. PubMed ID: 12756506
[TBL] [Abstract][Full Text] [Related]
25. Identification of candidate tumor-suppressor genes in 6q27 by combined deletion mapping and electronic expression profiling in lymphoid neoplasms.
Steinemann D; Gesk S; Zhang Y; Harder L; Pilarsky C; Hinzmann B; Martin-Subero JI; Calasanz MJ; Mungall A; Rosenthal A; Siebert R; Schlegelberger B
Genes Chromosomes Cancer; 2003 Aug; 37(4):421-6. PubMed ID: 12800155
[TBL] [Abstract][Full Text] [Related]
26. Novel tumor suppressor loci on 6q22-23 in primary central nervous system lymphomas.
Nakamura M; Kishi M; Sakaki T; Hashimoto H; Nakase H; Shimada K; Ishida E; Konishi N
Cancer Res; 2003 Feb; 63(4):737-41. PubMed ID: 12591717
[TBL] [Abstract][Full Text] [Related]
27. Loss of heterozygosity in the HLA class I region in human pancreatic cancer.
Ryschich E; Cebotari O; Fabian OV; Autschbach F; Kleeff J; Friess H; Bierhaus A; Büchler MW; Schmidt J
Tissue Antigens; 2004 Dec; 64(6):696-702. PubMed ID: 15546343
[TBL] [Abstract][Full Text] [Related]
28. Involvement of the chromosomal translocation t(11;18) in some mucosa-associated lymphoid tissue lymphomas and diffuse large B-cell lymphomas of the ocular adnexa: evidence from multiplex reverse transcriptase-polymerase chain reaction and fluorescence in situ hybridization on using formalin-fixed, paraffin-embedded specimens.
Takada S; Yoshino T; Taniwaki M; Nakamura N; Nakamine H; Oshima K; Sadahira Y; Inagaki H; Oshima K; Tadaatsu A
Mod Pathol; 2003 May; 16(5):445-52. PubMed ID: 12748251
[TBL] [Abstract][Full Text] [Related]
29. Alteration of chromosome arm 6p is characteristic of primary mediastinal B-cell lymphoma, as identified by genome-wide allelotyping.
Rigaud G; Moore PS; Taruscio D; Scardoni M; Montresor M; Menestrina F; Scarpa A
Genes Chromosomes Cancer; 2001 Jun; 31(2):191-5. PubMed ID: 11319807
[TBL] [Abstract][Full Text] [Related]
30. Loss of heterozygosity occurs via mitotic recombination in Trp53+/- mice and associates with mammary tumor susceptibility of the BALB/c strain.
Blackburn AC; McLary SC; Naeem R; Luszcz J; Stockton DW; Donehower LA; Mohammed M; Mailhes JB; Soferr T; Naber SP; Otis CN; Jerry DJ
Cancer Res; 2004 Aug; 64(15):5140-7. PubMed ID: 15289317
[TBL] [Abstract][Full Text] [Related]
31. Deletion mapping of 6q21-26 and frequency of 1p36 deletion in childhood endodermal sinus tumors by microsatellite analysis.
Hu J; Schuster AE; Fritsch MK; Schneider DT; Lauer S; Perlman EJ
Oncogene; 2001 Nov; 20(55):8042-4. PubMed ID: 11753688
[TBL] [Abstract][Full Text] [Related]
32. High frequency in vivo loss of heterozygosity is primarily a consequence of mitotic recombination.
Gupta PK; Sahota A; Boyadjiev SA; Bye S; Shao C; O'Neill JP; Hunter TC; Albertini RJ; Stambrook PJ; Tischfield JA
Cancer Res; 1997 Mar; 57(6):1188-93. PubMed ID: 9067291
[TBL] [Abstract][Full Text] [Related]
33. Loss of heterozygosity at chromosome 9p21 is a frequent finding in enteropathy-type T-cell lymphoma.
Obermann EC; Diss TC; Hamoudi RA; Munson P; Wilkins BS; Camozzi ML; Isaacson PG; Du MQ; Dogan A
J Pathol; 2004 Feb; 202(2):252-62. PubMed ID: 14743509
[TBL] [Abstract][Full Text] [Related]
34. Diffuse large B-cell lymphoma with extra Bcl-2 gene signals detected by FISH analysis is associated with a "non-germinal center phenotype".
Kusumoto S; Kobayashi Y; Sekiguchi N; Tanimoto K; Onishi Y; Yokota Y; Watanabe T; Maeshima AM; Ishida T; Inagaki H; Matsuno Y; Ueda R; Tobinai K
Am J Surg Pathol; 2005 Aug; 29(8):1067-73. PubMed ID: 16006802
[TBL] [Abstract][Full Text] [Related]
35. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
[TBL] [Abstract][Full Text] [Related]
36. Detailed mapping of chromosome 17p deletions reveals HIC1 as a novel tumor suppressor gene candidate telomeric to TP53 in diffuse large B-cell lymphoma.
Stöcklein H; Smardova J; Macak J; Katzenberger T; Höller S; Wessendorf S; Hutter G; Dreyling M; Haralambieva E; Mäder U; Müller-Hermelink HK; Rosenwald A; Ott G; Kalla J
Oncogene; 2008 Apr; 27(18):2613-25. PubMed ID: 17982487
[TBL] [Abstract][Full Text] [Related]
37. Identification of CCND3 and BYSL as candidate targets for the 6p21 amplification in diffuse large B-cell lymphoma.
Kasugai Y; Tagawa H; Kameoka Y; Morishima Y; Nakamura S; Seto M
Clin Cancer Res; 2005 Dec; 11(23):8265-72. PubMed ID: 16322284
[TBL] [Abstract][Full Text] [Related]
38. Unbalanced translocation, a major chromosome alteration causing loss of heterozygosity in human lung cancer.
Ogiwara H; Kohno T; Nakanishi H; Nagayama K; Sato M; Yokota J
Oncogene; 2008 Aug; 27(35):4788-97. PubMed ID: 18408757
[TBL] [Abstract][Full Text] [Related]
39. Regional loss of chromosome 6 in two urological malignancies.
Rukstalis DB; Bubley GJ; Donahue JP; Richie JP; Seidman JG; DeWolf WC
Cancer Res; 1989 Sep; 49(18):5087-90. PubMed ID: 2766279
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of interphase fluorescence in situ hybridization for the t(14;18)(q32;q21) translocation in the diagnosis of follicular lymphoma on fine-needle aspirates: a comparison with flow cytometry immunophenotyping.
Gong Y; Caraway N; Gu J; Zaidi T; Fernandez R; Sun X; Huh YO; Katz RL
Cancer; 2003 Dec; 99(6):385-93. PubMed ID: 14681948
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
